respiratori
viru
infect
common
around
world
especi
winter
season
infect
impos
enorm
econom
burden
lead
death
especi
among
elderli
respiratori
viru
infect
easili
transmit
one
person
anoth
caus
global
pandem
everi
thu
prevent
rapid
spread
minim
mortal
rate
essenti
diagnos
infect
soon
possibl
sever
laboratori
method
enzymelink
immunosorb
assay
nucleic
acid
hybrid
polymeras
chain
reaction
pcr
util
detect
respiratori
viru
howev
assay
highli
depend
previou
knowledg
viru
thu
ineffect
identifi
new
pathogen
less
effect
identifi
novel
variant
known
mainli
method
reli
knowledg
viral
sequenc
hand
henc
relev
nucleic
acid
probe
primer
use
accordingli
rare
virus
commonli
examin
laboratori
detect
use
convent
method
nextgener
sequenc
ng
technolog
enabl
simultan
sequenc
larg
number
sampl
use
unbias
detect
character
multipl
agent
singl
sampl
use
ng
elimin
need
prior
knowledg
viru
genom
sequenc
provid
advantag
tradit
method
pcr
amplif
microarray
hybrid
depend
targetspecif
date
ng
instrument
discoveri
novel
virus
character
viral
commun
ng
use
discov
new
new
ebola
zika
ng
also
appli
character
virus
describ
new
ngsbase
method
design
identifi
virus
pool
clinic
sampl
part
commun
influenza
surveil
conduct
collabor
israel
center
diseas
control
icdc
clinic
combin
nose
throat
swab
sampl
collect
patient
present
influenzalik
ill
ili
winter
season
span
octob
decemb
sampl
collect
use
compliant
kit
mwe
uk
suspend
ml
medium
store
hour
follow
prepar
sampl
store
microlit
use
first
prepar
rest
kept
step
fig
use
origin
sampl
control
store
commun
influenza
surveil
includ
combin
nose
throat
sampl
perform
public
health
ordin
enact
israel
irb
sheba
medic
center
approv
research
helsinki
number
inform
consent
requir
total
nucleic
acid
content
extract
microlit
virocult
medium
use
nuclisen
easymag
biomerieux
franc
presenc
respiratori
virus
determin
taqman
chemistri
use
abi
instrument
part
commun
influenza
surveil
rna
virus
detect
perform
use
panel
realtim
revers
transcriptionpolymeras
chain
reaction
rrtpcr
assay
previous
describ
influenza
influenza
respiratori
syncyti
viru
rsv
sampl
test
presenc
human
parainfluenza
rtpcr
perform
detect
dna
viru
rna
rrtpcr
assay
ambion
agpath
master
mix
life
technolog
carlsbad
ca
use
wherea
dna
assay
abgen
absolut
blue
thermo
uk
use
use
accord
manufactur
instruct
torqu
teno
viru
ttv
detect
parainfluenza
viru
detect
rtpcr
previous
cucumb
green
mottl
mosaic
viru
cgmmv
detect
use
follow
primer
forward
revers
bacteria
streptococcu
pneumonia
detect
pcr
previous
use
follow
primer
forward
revers
staphylococcu
aureu
detect
pcr
previous
use
follow
primer
forward
revers
pseudomona
putida
detect
pcr
previous
use
follow
primer
forward
revers
influenza
c
parainfluenza
detect
rtpcr
sampl
second
run
rna
librari
microlit
origin
sampl
store
virocult
medium
freezethaw
three
time
centrifug
high
speed
minut
omnicleav
endonucleas
epicent
distributor
madison
wi
usa
ad
supernat
presenc
mm
h
genom
extract
sampl
use
nuclisen
easymag
rnasep
content
quantifi
qrtpcr
serv
indic
amount
human
genom
remain
sampl
rnasep
ct
qrtpcr
pool
togeth
agil
rna
nano
kit
life
technolog
waldbronn
germani
use
evalu
total
rna
qualiti
rna
concentr
measur
use
qubit
rna
br
assay
kit
life
technolog
librari
process
ng
sampl
prepar
use
smarter
strand
rnaseq
kit
clontech
takara
bio
compani
ca
usa
strandspecif
librari
construct
transcriptom
analysi
illumina
platform
agil
high
sensit
dna
kit
agil
bioanalyz
life
technolog
waldbronn
germani
use
size
quantifi
qualiti
control
dna
sequenc
librari
ng
perform
use
miseq
kit
cycl
illumina
san
diego
ca
autom
cluster
gener
miseq
sequenc
process
genom
sequenc
read
obtain
detect
rna
virus
sampl
extract
pretreat
rnase
free
dnase
promega
agil
rna
nano
kit
life
technolog
waldbronn
germani
use
evalu
total
rna
qualiti
rna
concentr
measur
use
qubit
rna
hs
assay
kit
life
technolog
rna
librari
construct
ng
use
smarter
strand
rnaseq
kit
accord
manufactur
instruct
clontech
takara
bio
compani
ca
usa
dna
virus
sampl
extract
pretreat
rnase
jgi
dna
concentr
measur
use
qubit
dna
hs
assay
kit
dna
librari
construct
use
nextera
xt
kit
illumina
san
diego
ca
accord
manufactur
instruct
rna
dna
librari
size
distribut
analyz
use
tape
station
agil
librari
normal
accord
median
fragment
size
measur
tape
station
librari
concentr
measur
qubit
sequenc
process
miseq
kit
cycl
illumina
san
diego
ca
autom
cluster
gener
genom
sequenc
read
fastq
file
obtain
analysi
bowti
use
filter
read
map
either
human
genom
human
transcriptom
download
ensembl
wwwensemblorg
b
bacteri
genom
list
human
microbiom
project
download
http
hmpdaccorg
remain
read
queri
use
bowti
virusonli
databas
download
ncbi
ftp
ftpncbinihgovrefseqreleasevir
hit
valid
blastn
blastx
omit
read
map
virus
map
viru
blast
order
examin
read
map
databas
describ
use
velvet
denovo
assembl
default
set
creat
larger
contig
data
final
contig
queri
nt
nonredund
nucleotid
nr
nonredund
protein
databas
ncbi
use
blastn
blastx
respect
default
paramet
begin
winter
season
ident
virus
caus
il
rsv
influenza
unknown
fig
later
winter
two
epidem
wave
notic
rsv
influenza
howev
higher
percentag
patient
still
suffer
respiratori
infect
unknown
etiolog
clinic
symptom
compat
viral
infect
fig
therefor
set
develop
gener
robust
approach
identifi
unknown
virus
respons
il
three
possibl
consid
caus
il
unknown
viru
known
viru
yet
associ
respiratori
ill
caus
il
viru
commonli
test
laboratori
caus
il
known
viru
caus
respiratori
infect
identifi
routin
rt
pcr
test
due
variabl
workflow
approach
shown
fig
initi
qrtpcr
influenza
rsv
perform
sampl
obtain
begin
winter
season
fig
sampl
posit
remain
sampl
fig
assay
qrtpcr
rhinoviru
enteroviru
adenoviru
parainfluenza
bocaviru
coronavirus
sampl
found
posit
fig
next
step
remain
sampl
posit
control
sampl
influenza
influenza
b
rsv
adenoviru
treat
omnicleav
destroy
free
dna
rna
leav
viral
genom
unaffect
protect
capsid
qrtpcr
sampl
cellular
gene
rnasep
perform
follow
treatment
control
viru
amount
remain
unchang
rnasep
level
reduc
result
higher
cycl
threshold
ct
fig
treatment
effici
threshold
set
ct
rnasep
select
ct
sinc
indic
low
level
human
genom
interfer
viral
identif
level
ct
equival
less
one
copi
human
dna
ct
control
virus
two
one
influenza
b
sampl
ct
one
adenoviru
sampl
ct
mix
sequenc
took
one
sampl
control
viru
follow
clinic
sampl
left
addit
control
sampl
influenza
b
rsv
adenoviru
fig
sampl
pool
ng
perform
fig
result
ng
data
consist
pairedend
read
bp
dna
fragment
read
similar
human
known
bacteri
genom
filter
remain
read
test
similar
virus
known
databas
previous
among
read
found
human
genom
materi
map
bacteri
genom
filter
leav
million
read
analyz
appli
bowti
match
remain
read
known
virus
approxim
map
known
virus
read
map
phi
x
bacteriophag
control
sampl
illumina
sequenc
remain
million
unmap
read
assembl
larger
segment
contig
assum
read
pathogen
abund
enough
sampl
creat
somewhat
long
contig
contig
nucleotid
detect
use
queri
nonredund
nucleotid
protein
databas
ncbi
vast
major
contig
map
bacteri
phage
sourc
remain
viralmap
contig
map
influenza
b
torqu
teno
viru
ttv
one
contig
map
human
picobirnaviru
small
number
contig
map
plant
fungi
anim
protist
next
focus
read
map
known
virus
map
bacteri
phage
virus
latter
read
three
virus
adenoviru
rsv
influenza
b
includ
posit
sampl
pool
sampl
detect
fig
notabl
averag
coverag
posit
control
virus
quit
low
sixteen
read
per
base
adenoviru
one
read
per
base
rsv
influenza
b
addit
virus
identifi
includ
parainfluenza
viru
ttv
viru
frequent
present
human
cucumb
green
mottl
mosaic
viru
cgmmv
present
veget
like
cucumb
watermelon
known
caus
ill
human
fig
tabl
valid
newli
identifi
virus
inde
present
test
sampl
determin
precis
sampl
infect
virus
qrtpcr
perform
individu
sampl
seen
fig
ttv
detect
sampl
unidentifi
sampl
control
sampl
ttv
titer
high
two
unidentifi
sampl
low
rest
sampl
detect
control
virus
includ
pool
assay
sampl
identifi
control
sampl
fig
one
patient
number
fig
infect
parainfluenza
viru
three
patient
cgmmv
known
caus
ill
human
fig
human
picobirnaviru
detect
one
contig
assembl
viru
caus
gastroenter
symptom
associ
although
studi
focus
patient
viral
symptom
rather
bacteri
symptom
reason
assum
patient
infect
bacteri
agent
sequenc
result
million
read
map
bacteria
bacteri
read
map
pseudomona
genu
mostli
nonpathogen
pathogen
usual
due
opportunist
genu
detect
high
preval
streptococcu
read
speci
genu
streptococcu
pneumonia
k
read
caus
diseas
influenza
like
symptom
anoth
possibl
caus
agent
il
detect
staphylococcu
aureu
k
read
map
import
acknowledg
bacteri
result
obtain
repres
full
repertoir
bacteria
sampl
due
omnicleav
treatment
destroy
bacteri
genom
determin
sampl
infect
bacteri
strain
perform
pcr
individu
sampl
pseudomona
putida
preval
pseudomona
speci
found
present
sampl
low
quantiti
staphylococcu
aureu
detect
strong
signal
one
sampl
patient
fig
weak
signal
two
sampl
adenoviru
posit
control
streptococcu
pneumonia
detect
sampl
fig
result
impli
least
one
patient
sampl
il
symptom
may
result
bacteri
infect
staphylococcu
aureu
quit
possibl
bacteri
strain
caus
il
symptom
sampl
detect
concern
initi
cutoff
sampl
inclus
might
stringent
perform
second
round
ng
sequenc
time
includ
neg
sampl
split
pool
sampl
two
creat
separ
sampl
rna
virus
dna
virus
use
treatment
dnase
rnase
respect
maxim
librari
qualiti
probabl
viral
detect
sequenc
result
rna
virus
sampl
reveal
three
addit
virus
detect
first
sequenc
virus
parainfluenza
viru
influenza
c
viru
caus
il
symptom
rotaviru
caus
diarrhoeal
diseas
parainfluenza
influenza
c
identifi
rtpcr
two
clinic
sampl
parainfluenza
patient
number
influenza
c
patient
dna
virus
sampl
reveal
presenc
previous
undetect
virus
infect
respiratori
virus
common
affect
practic
entir
popul
infect
impos
heavi
econom
burden
due
loss
work
day
lifethreaten
thu
critic
monitor
infect
earli
stage
howev
occasion
viru
respons
infect
identifi
exampl
show
start
screen
common
respiratori
viru
could
identifi
sampl
collect
patient
il
furthermor
new
method
need
rapidli
detect
virus
present
pool
sampl
enabl
rapid
treatment
popul
case
pandem
present
new
ngsbase
method
identifi
virus
present
sampl
method
unknown
sampl
pool
posit
control
enabl
viru
identif
singl
experi
render
approach
rapid
robust
effici
econom
take
less
one
day
perform
qrtpcr
one
day
gener
librari
sequenc
bioinformat
analysi
run
hour
next
presenc
identifi
viru
sampl
rapidli
determin
use
qrtpcr
sampl
sequenc
method
discov
infect
human
parainfluenza
viru
human
parainfluenza
viru
influenza
c
viru
one
patient
origin
clinic
diagnosi
sampl
infect
viral
agent
base
symptom
nevertheless
method
also
detect
sampl
like
infect
bacteri
agent
rather
viral
one
interestingli
ttv
identifi
mani
sampl
ttv
first
human
viru
identifi
circular
negativestrand
dna
genom
approxim
nucleotid
nt
ttv
frequent
circul
mani
geograph
although
viru
high
preval
gener
popul
neither
interact
host
direct
involv
etiolog
specif
diseas
fulli
understood
nevertheless
signific
correl
ttv
load
airflow
limit
within
peripher
airway
well
sever
bronchiectasi
decreas
lung
function
thu
possibl
ttv
caus
il
studi
necessari
confirm
ttv
inde
respons
il
understand
ttv
present
individu
even
healthi
other
detect
cgmmv
demonstr
method
identifi
virus
present
human
diet
provid
indic
valid
accuraci
present
method
viru
respons
infect
could
certainli
identifi
sampl
follow
hypothes
may
rais
sourc
diseas
bacteri
rather
viral
suggest
herein
one
sampl
may
infect
staphylococcu
aureu
inde
case
unidentifi
sampl
bacteri
dna
may
destroy
use
omnicleav
endonucleas
see
method
b
sourc
diseas
ttv
c
sourc
diseas
viral
due
low
viru
titer
undetect
accordingli
suggest
futur
improv
sampl
prepar
process
strive
higher
sequenc
depth
aim
discov
new
viru
novel
viru
variant
summari
present
rapid
effici
method
detect
novel
uncommon
nontest
pathogen
associ
diseas
might
use
clinic
set
advanc
ng
technolog
expect
approach
becom
increasingli
use
